GSTM1 and GSTT1 polymorphism and susceptibility to esophageal cancer in high- and low-risk regions of India

Tumor Biology

Volumn 34, Issue 5, 2013, Pages 3249-3257

  Sharma, Anita ^a   Das, Bhudev Chander ^b   Sehgal, Ashok ^a   Mehrotra, Ravi ^a   Kar, Premashish ^c   Sardana, Sarita ^a   Phukan, Rup ^d   Mahanta, Jagdish ^d   Purkayastha, Joydeep ^e   Saxena, Sunita ^f   Kapur, Sujala ^f   Chatterjee, Indranil ^g   Sharma, Joginder Kumar ^a  

^a Institute of Cytology and Preventive Oncology ICMR   (India)

^b UNIVERSITY OF DELHI   (India)

^c MAULANA AZAD MEDICAL COLLEGE   (India)

^d REGIONAL MEDICAL RESEARCH CENTRE   (India)

^e Surgical Oncology ^*  (India)

^f SAFDARJUNG HOSPITAL   (India)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Esophageal cancer; Glutathione transferase; GSTM1; GSTT1; Polymorphism

Indexed keywords

EID: 84885417009     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0897-6     Document Type: Article

References (47)

1. Zhang GH, Mai RQ, Huang B. Meta-analysis of ADH1B and ALDH2 polymorphisms and esophageal cancer risk in China. World J Gastroenterol. 2010;16:6020-5.
2. Lukanich JM. Section I: epidemiological review. Semin Thorac Cardiovasc Surg. 2003;15:158-66.
3. Demeester SR. Epidemiology and biology of esophageal cancer. Gastrointest Cancer Res. 2009;3:S2-5.
4. Stewart B, Kleihues PE. World cancer report. lyon: Iarc press; 2003.
5. Chitra SAL, Anand L, Srinivasan V, Jayanthi V. Risk factors for esophageal cancer in Coimbatore, southern India: a hospital-based case-control study. Indian J Gastroenterol. 2004;23:19-21.
6. Ansari MM, Beg MH, Haleem S. Clinicopathological profile of carcinoma of oesophagus at Aligarh. J Indian Med Assoc. 1991;89:217-9.
7. Khuroo MS, Zargar SA, Mahajan R, Banday MA. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut. 1992;33:11-5.
8. Mannervik B, Awasthi YC, Board PG, Hayes JD, Di Ilio C, Ketterer B, et al. Nomenclature for human glutathione transferases. Biochem J. 1992;282(Pt 1):305-6.
9. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51-88.
10. Hayes JD, Pulford DJ. The glutathione s-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445-600.
11. Sharma A, Pandey A, Sardana S, Sehgal S, Sharma JK. Genetic polymorphisms of GSTM1 and GSTT1 genes in Delhi and comparison with other Indian and global populations. Asian Pac J Cancer Prev. 2012;13:5647-52.
12. Mikelsaar AV, Tasa G, Parlist P, Uuskula M. Human glutathione s-transferase GSTM1 genetic polymorphism in Estonia. Hum Hered. 1994;44:248-51.
13. Zhang ZF, Kurtz RC, Klimstra DS, Yu GP, Sun M, Harlap S, et al. Helicobacter pylori infection on the risk of stomach cancer and chronic atrophic gastritis. Cancer Detect Prev. 1999;23:357-67.
14. Board PG. Biochemical genetics of glutathione-s-transferase in man. Am J Hum Genet. 1981;33:36-43.
15. Rossini A, Rapozo DC, Amorim LM, Macedo JM, Medina R, Neto JF, et al. Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population. Genet Mol Res. 2002;1:233-40.
16. Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione s-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics. 1996;6:187-91.
17. Setiawan VW, Zhang ZF, Yu GP, Li YL, Lu ML, Tsai CJ, et al. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. Cancer Epidemiol Biomark Prev. 2000;9:73-80.
18. Kiyohara C, Wakai K, Mikami H, Sido K, Ando M, Ohno Y. Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women. Int J Cancer. 2003;107:139-44.
19. Lee JM, Lee YC, Yang SY, Shi WL, Lee CJ, Luh SP, et al. Genetic polymorphisms of p53 and GSTP1, but not nat2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer. 2000;89:458-64.
20. Roth MJ, Dawsey SM, Wang GQ, Tangrea JA, Zhou BRD, Woodson KG, et al. Association between GSTM1*0 and squamous dysplasia of the esophagus in the high risk region of Linxian, China. Cancer Lett. 2000;156:73-81.
21. Wang AH, Sun CS, Li LS, Huang JY, Chen QS. Relationship of tobacco smoking CYP1A1 GSTM1 gene polymorphism and esophageal cancer in Xi'an. World J Gastroenterol. 2002;8:49-53.
22. Gao C, Takezaki T, Wu J, Li Z, Wang J, Ding J, et al. Interaction between cytochrome p-450 2E1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese. Cancer Epidemiol Biomark Prev. 2002;11:29-34.
23. Tan W, Song N, Wang GQ, Liu Q, Tang HJ, Kadlubar FF, et al. Impact of genetic polymorphisms in cytochrome p450 2e1 and glutathione s-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomark Prev. 2000;9:551-6.
24. Rebbeck TR. Molecular epidemiology of the human glutathione s-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomark Prev. 1997;6:733-43.
25. NCRP (ICMR) (2008) Second report of north east population based cancer registries 2005-2006: Bangalore
26. Sharma A, Sharma JK, Murthy NS, Mitra AB. Polymorphisms at GSTM1 and GSTT1 gene loci and susceptibility to cervical cancer in Indian population. Neoplasma. 2004;51:12-6.
27. Lu XM, Zhang YM, Lin RY, Arzi G, Wang X, Zhang YL, et al. Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China. World J Gastroenterol. 2005;11:3651-4.
28. Wang LD, Zheng S, Liu B, Zhou JX, Li YJ, Li JX. CYP1A1, GSTS and MEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high-incidence area in north China. World J Gastroenterol. 2003;9:1394-7.
29. Hori H, Kawano T, Endo M, Yuasa Y. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility. J Clin Gastroenterol. 1997;25:568-75.
30. Yokoyama A, Kato H, Yokoyama T, Tsujinaka T, Muto M, Omori T, et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione s-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma. Carcinogenesis. 2002;23:1851-9.
31. van Lieshout EM, Roelofs HM, Dekker S, Mulder CJ, Wobbes T, Jansen JB, et al. Polymorphic expression of the glutathione s-transferase p1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. Cancer Res. 1999;59:586-9.
32. Nimura Y, Yokoyama S, Fujimori M, Aoki T, Adachi W, Nasu T, et al. Genotyping of the CYP1A1 and GSTM1 genes in esophageal carcinoma patients with special reference to smoking. Cancer. 1997;80:852-7.
33. Shao G, Su Y, Huang G, Wen B. Relationship between CYP1A1, GSTM1 genetic polymorphisms and susceptibility to esophageal squamous cell carcinoma. Zhonghua Liu Xing Bing Xue Za Zhi. 2000;21:420-3.
34. Morita S, Yano M, Shiozaki H, Tsujinaka T, Ebisui C, Morimoto T, et al. CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer. 1997;71:192-5.
35. Lin D, Tang Y, Lu S. Glutathione s-transferase M1, T1 genotypes and the risk of esophageal cancer: a case-control study. Zhonghua Liu Xing Bing Xue Za Zhi. 1998;19:195-9.
36. Yang CX, Matsuo K, Wang ZM, Tajima K. Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature. World J Gastroenterol. 2005;11:2531-8.
37. Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch H, Stanford JL, et al. GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect Prev. 2007;31:233-6.
38. Lin DX, Tang YM, Peng Q, Lu SX, Ambrosone CB, Kadlubar FF. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione s-transferases T1, P1, and M1 and cytochrome P450 2E1. Cancer Epidemiol Biomark Prev. 1998;7:1013-8.
39. Hashibe M, Brennan P, Strange RC, Bhisey R, Cascorbi I, Lazarus P, et al. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomark Prev. 2003;12:1509-17.
40. Casson AG, Zheng Z, Chiasson D, MacDonald K, Riddell DC, Guernsey JR, et al. Associations between genetic polymorphisms of phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev. 2003;27:139-46.
41. Rossini A, Rapozo DC, Soares Lima SC, Guimaraes DP, Ferreira MA, Teixeira R, et al. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population. Carcinogenesis. 2007;28:2537-42.
42. Ji R, Wu J, YN Z. Relationship between CYP1A1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility of esophageal cancer in Wuwei, Gansu province. J Lanzhou Univ Med Sci. 2010;36:29-34.
43. London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR. Polymorphism of glutathione s-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst. 1995;87:1246-53.
44. Roberta LG, Luciana PGD, Ilce MSC. Glutathione s-transferase mu (GSTM1) null genotype in relation to gender, age and smoking status in a healthy Brazilian population. Genet Mol Biol. 2002;25:357-60.
45. Rossit ARB, Cabral IR, Hamel AR, Conforti-Froes NDT. Estariam as freqüências de genes do biometabolismo sujeitas à pressão seletiva durante o desenvolvimento humano?Iv congresso da sociedade brasileira de mutagênese, carcinogênese e teratogênese ambiental, águas de lindóia, Brazil. Genet Molec Biol. 1999;22(suppl):218.
46. Phukan RK, Ali MS, Chetia CK, Mahanta J. Betel nut and tobacco chewing; potential risk factors of cancer of oesophagus in Assam, India. Br J Cancer. 2001;85:661-7.
47. Garavello W, Negri E, Talamini R, Levi F, Zambon P, Dal Maso L, et al. Family history of cancer, its combination with smoking and drinking, and risk of squamous cell carcinoma of the esophagus. Cancer Epidemiol Biomark Prev. 2005;14:1390-3.